Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies

অনুরূপ উপাদানগুলি

• Efficacy of Secukinumab on Moderate-to-severe Plaque Psoriasis Affecting Different Body Regions: a Pooled Analysis of Four Phase 3 Studies
  অনুযায়ী: Menter, Alan, অন্যান্য
  প্রকাশিত: (2016)
• Efficacy of Secukinumab for Moderate-to-Severe Head and Neck Psoriasis Over 52 Weeks: Pooled Analysis of Four Phase 3 Studies
  অনুযায়ী: Kircik, Leon, অন্যান্য
  প্রকাশিত: (2016)
• Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials
  অনুযায়ী: Adsit, Sandra, অন্যান্য
  প্রকাশিত: (2017)
• Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials
  অনুযায়ী: Adsit, Sandra, অন্যান্য
  প্রকাশিত: (2017)
• Population Pharmacokinetic Modeling of Secukinumab in Patients With Moderate to Severe Psoriasis
  অনুযায়ী: Bruin, Gerard, অন্যান্য
  প্রকাশিত: (2017)